Medican Pharmsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-01-28
Share capital
20,000.00 PLN
Registered address
ul. Na Zakolu Wisły 12B/Lu2, 30-729 Kraków, Poland
Electronic delivery address
AE:PL-22431-86301-FACRR-24

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 73 days for 2021).

  • 202515/05/2026
  • 202430/07/2025
  • 202322/07/2024
  • 202207/09/2023
  • 202126/09/2022
  • 202030/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 33.83kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -385.74kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 400.26kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 102.16kMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Marek Bielski – Management Board Member
Wioletta Karteczka Szostak – President of the Management Board
Marcin Kukla – Vice President of the Management Board
Mateusz Kycia – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, the company shall be represented by the only member of the management board. In the case of a multi-member management board, two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, shall be authorised to submit declarations of will on behalf of the company and to represent it.

Ownership

OwnerSharesShare valueStake
Wiesław Kuklaage 70
25$1,350.6225%
Medican Group P.S.A.
75–42.8571%
Others
300$4,051.8675%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $81,918.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$0
Regional investment aid
$0
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$0

European Funds

ProjectEU co-financing
Development of Medican Pharm through the development of a method for producing and using a new product in the form of an oral gel containing the active substance THC.
$79,861

Competitors

Name
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A.
Fagronsp. z o.o.
Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A.
F1 PharmaS.A.
BIO Animalisp. z o.o.
Ampliconsp. z o.o.
Xenira Pharmaceuticalssp. z o.o.
Sanford Biotechsp. z o.o.
Cefeasp. z o.o.
Zakład Farmaceutyczny Amarasp. j.

FAQ

Last updated: 2026-05-15